
Venture capital
Rosetta Capital
UK-based specialist venture capital firm investing in life sciences and medical device companies worldwide, primarily by buying stakes from existing holders in direct secondary transactions.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Rosetta Capital right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
Rounds Rosetta Capital joined, from press and the firm’s own posts.
Every round Rosetta Capital joined
Round sizes, Rosetta Capital’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Rosetta Capital backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Rosetta Capital
Events where Rosetta Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Rosetta Capital is based in Haddenham, United Kingdom. It also has offices in Oxford and London.
4 fund vehicles are on public registers (SEC adviser filings), including ROSETTA CAPITAL VII LP, ROSETTA CAPITAL VI LP and ROSETTA CAPITAL IV LP.
Sectors: Life sciences, Biotech, Medtech. From the firm’s own website.
Rosetta buys equity in late-preclinical and clinical-stage healthcare companies through direct secondary deals, giving sellers liquidity before an exit. It then backs the companies with follow-on financing and works with boards, management and co-investors toward partnerships, IPOs and trade sales. From the firm’s own website.
Rosetta Capital lists 40 portfolio companies on its website, including Aegera, Ambit, Aprea, Asarina and Biosergen.
Firms whose websites list some of the same companies include START CODON LTD, 5AM Ventures and ARCH Venture Partners.
Know before Rosetta Capital’s next round is announced.
PRO tracks Rosetta Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.